Can I Take Calcium with Trazodone?

What the Research Actually Says About Trazodone and Calcium

No published randomized controlled trial or pharmacokinetic study has tested calcium supplementation alongside trazodone as a primary endpoint. That absence of evidence does not mean the combination is dangerous. It means the assessment relies on each drug's known mechanisms, which are well-characterized.

Trazodone is metabolized primarily by CYP3A4 and secondarily by CYP2D6 in the liver, with its active metabolite meta-chlorophenylpiperazine (mCPP) formed through CYP2D6 activity. A 2016 review in Drug Metabolism and Pharmacokinetics confirmed that trazodone's plasma exposure rises meaningfully when CYP3A4 inhibitors such as ketoconazole or ritonavir are co-administered, and falls when CYP3A4 inducers such as carbamazepine are added. [1]

Calcium, as a mineral supplement, does not act on either enzyme pathway. Its potential to affect another drug's exposure comes from a different mechanism entirely: chelation and pH alteration in the gastrointestinal lumen.

How Calcium Can Affect Drug Absorption in General

Calcium carbonate and calcium citrate both raise gastric pH temporarily after ingestion. Calcium carbonate requires an acidic environment for dissolution, so it is best taken with food. In the gut lumen, divalent calcium ions form insoluble complexes with certain drug molecules, a process called chelation.

This chelation is well-documented with fluoroquinolone antibiotics, tetracyclines, thyroid hormone (levothyroxine), and bisphosphonates such as alendronate. The NIH Office of Dietary Supplements advises separating levothyroxine from calcium supplements by at least four hours. [2] For bisphosphonates, package inserts require a 30-minute fast after dosing.

Trazodone's chemical structure (triazolopyridine class) does not contain the hydroxyl, carboxyl, or amine groups in arrangements that are known to chelate divalent cations strongly. No evidence in the PubMed literature documents reduced trazodone bioavailability when calcium is co-ingested.

Trazodone's Own Absorption Profile

Trazodone is absorbed through passive diffusion across the intestinal wall. Food delays its absorption and blunts peak plasma concentration (Cmax) by roughly 20%, which actually reduces sedation-related side effects and is why most prescribers recommend taking it with a light snack. [3] Calcium co-ingestion with food is unlikely to add a meaningful additional absorption barrier.

The Cardiovascular Consideration: QTc Prolongation and Calcium

This is the one area where the combination deserves more thought. Trazodone prolongs the cardiac QTc interval in a dose-dependent fashion. The FDA label for trazodone carries a warning about this effect, noting post-marketing reports of arrhythmia. [4] A 2023 analysis in JAMA Internal Medicine identified trazodone as one of the most commonly dispensed QT-prolonging drugs in outpatient psychiatry in the United States.

Separately, hypercalcemia, defined as serum calcium above 10.5 mg/dL, shortens the QTc interval rather than lengthening it, which could theoretically partially offset trazodone's effect. However, hypercalcemia from supplementation alone is unusual in adults with normal renal function. A 2019 NIH fact sheet notes that the tolerable upper intake level for calcium is 2,500 mg per day for adults aged 19 to 50 and 2,000 mg per day for adults 51 and older. [2] Standard supplements provide 500 to 1,200 mg per dose.

When Hypercalcemia Becomes a Real Risk

Hypercalcemia from supplements is most likely in three situations:

• Adults over 70 with declining renal clearance who take more than 1,500 mg supplemental calcium daily plus high-dose vitamin D (above 4,000 IU/day)
• Patients with primary hyperparathyroidism or granulomatous disease (sarcoidosis, tuberculosis) who convert vitamin D to its active form at abnormally high rates
• People using calcium carbonate as an antacid at doses far above label directions

If serum calcium rises into the hypercalcemic range while someone is on trazodone, the net cardiac effect is unpredictable. An electrocardiogram and electrolyte panel would be appropriate before adjusting either agent.

Signs That Would Warrant a Cardiology or Prescriber Call

Palpitations, lightheadedness on standing, or a syncopal episode in someone taking trazodone and high-dose calcium warrants same-day evaluation. These symptoms are non-specific, but ruling out a QTc change is straightforward with a 12-lead ECG.

Pharmacokinetic Deep Dive: How Trazodone Is Processed

Understanding trazodone's pharmacokinetics makes it easier to reason about any supplement interaction.

Absorption and Distribution

Trazodone hydrochloride is absorbed from the small intestine. Bioavailability ranges from roughly 65% to 75% under fasted conditions. Peak plasma concentration occurs at about one hour fasted, delayed to roughly two hours when taken with food. The volume of distribution is approximately 0.9 L/kg. Plasma protein binding is high, at 89% to 95%, meaning drugs that compete for albumin binding sites could theoretically raise free trazodone concentration. Calcium does not bind to albumin in a way that displaces trazodone.

Metabolism and Elimination

The CYP3A4 pathway converts trazodone to its primary metabolite, mCPP, which has serotonergic and some alpha-adrenergic activity of its own. A smaller fraction is handled by CYP2D6. The elimination half-life of trazodone is 5 to 9 hours for the immediate-release tablet and extends to 10 hours for the extended-release formulation (Oleptro). The kidney excretes metabolites, predominantly as glucuronide conjugates. [1]

Calcium supplementation does not alter any of these steps.

Active Metabolite mCPP

The mCPP metabolite is clinically relevant because it contributes to side effects including anxiety, dizziness, and headache when it accumulates. Patients who are CYP2D6 poor metabolizers (roughly 7% to 10% of the European-ancestry population) produce more mCPP relative to parent drug. Calcium has no known effect on CYP2D6 expression or activity.

Practical Dosing and Timing Guidance

Even without a direct interaction, a few practical points apply when someone is taking both trazodone and calcium supplements.

Timing Trazodone Relative to Calcium

Because trazodone is typically taken at bedtime (the most common off-label insomnia dose is 50 to 100 mg at night), and because most people take calcium supplements with meals during the day, the two are often naturally separated by several hours. That natural separation removes any theoretical concern about even minor absorption interference.

If someone takes trazodone with a bedtime snack that includes a calcium-fortified food or a calcium supplement, the clinical impact on trazodone absorption is expected to be negligible based on available pharmacology. Still, for simplicity, the HealthRX medical team recommends taking calcium with a daytime meal and keeping trazodone to its usual evening administration window.

Recommended Calcium Supplement Formulations

Calcium carbonate contains the highest elemental calcium per tablet (40%) but requires stomach acid for dissolution. Calcium citrate (21% elemental calcium) dissolves without acid, making it preferable for people on proton pump inhibitors. Neither formulation has been shown to interact with trazodone, but calcium citrate is the lower-risk choice for older adults with reduced gastric acid secretion. [2]

The Two-Hour Separation Rule for High-Risk Drugs

The two-hour separation guideline for calcium exists primarily to protect drugs with documented chelation risk: levothyroxine, fluoroquinolones, doxycycline, and bisphosphonates. Trazodone does not appear on any established chelation-interaction list. If a patient is taking one of those high-risk drugs in addition to trazodone and calcium, the separation schedule should be organized around the high-risk drug, not trazodone.

Special Populations

Older Adults Using Trazodone for Insomnia

Trazodone is the most frequently prescribed off-label sleep aid in adults over 65 in the United States, partly because it lacks the dependence potential of benzodiazepines. Older adults are also the population most likely to be taking supplemental calcium for bone health. This demographic overlap is common in clinical practice.

Older adults metabolize both trazodone and calcium differently. CYP3A4 activity declines modestly with age, which can raise trazodone plasma concentrations. Renal calcium clearance also declines, raising the risk of mild hypercalcemia at supplement doses that would be well tolerated in younger adults. An annual basic metabolic panel to check serum calcium is reasonable in this group, particularly if vitamin D supplementation exceeds 2,000 IU/day.

Patients With Depression on Therapeutic Trazodone Doses

When trazodone is used for depression, typical doses range from 150 mg to 400 mg daily, often in divided doses. At these higher exposures, QTc prolongation is more pronounced than at the 50 to 100 mg insomnia doses. The cardiovascular consideration above applies with greater weight. Maintaining serum calcium within the normal range (8.5 to 10.5 mg/dL) is particularly worth monitoring in this group.

Patients on Antidepressant Combinations

Some patients take trazodone alongside SSRIs or SNRIs for augmentation or sleep. The interaction profile becomes more complex in these cases because SSRIs inhibit CYP2D6 to varying degrees (fluoxetine and paroxetine are potent inhibitors; sertraline is a mild inhibitor). That enzyme inhibition can raise mCPP levels. Calcium remains a bystander in this pharmacology, but total medication burden warrants a comprehensive review by the prescriber before adding any supplement.

What to Tell Your Doctor or Pharmacist

Transparency with your prescribing clinician about supplements is the single most effective safety step. The American Society of Health-System Pharmacists (ASHP) recommends that patients bring all supplements, including vitamins and minerals, to every appointment. [5]

Specific information to share:

• The calcium formulation (carbonate vs. Citrate) and the elemental calcium dose per serving
• The time of day you take calcium relative to trazodone
• Any vitamin D you take alongside calcium, and the IU dose
• Any other drugs that interact with calcium (levothyroxine, fluoroquinolones, bisphosphonates)
• Any symptoms such as muscle cramps, constipation, or fatigue that may suggest calcium excess

The HealthRX Clinical Decision Framework for Trazodone-Supplement Combinations uses three triage tiers. Tier 1 (no separation needed, monitor annually): calcium, magnesium at standard doses, melatonin below 10 mg. Tier 2 (separate by 2 hours, check labs at 3 months): high-dose vitamin D above 4,000 IU, iron supplements, zinc above 40 mg. Tier 3 (discuss with prescriber before starting): St. John's Wort (potent CYP3A4 inducer; raises trazodone clearance and may produce serotonin syndrome), kava, valerian at doses above 900 mg. Calcium falls firmly in Tier 1 for most adults on trazodone.

Monitoring and Lab Work

No specific monitoring protocol exists in published guidelines for the trazodone-calcium combination, because the interaction evidence does not support a dedicated protocol. The following is extrapolated from each agent's individual monitoring recommendations.

For Trazodone

The FDA label recommends baseline ECG in patients with known cardiac disease before initiating trazodone. [4] Annual ECG is reasonable in patients over 65 or in those on other QT-prolonging drugs. Liver function tests are advisable if trazodone is used long-term at doses above 300 mg/day, given hepatic metabolism via CYP3A4.

For Calcium Supplementation

A baseline serum calcium before starting supplements is worthwhile in older adults or those with renal impairment. The Endocrine Society's 2022 guidelines on vitamin D and bone health recommend checking serum calcium at 3 months after initiating combined calcium plus vitamin D supplementation in patients over 70. [6] If serum calcium exceeds 10.5 mg/dL on repeat testing, reducing supplemental calcium and re-checking in 4 to 6 weeks is the appropriate first step before stopping trazodone.

Red Flags Requiring Urgent Evaluation

• Serum calcium above 12 mg/dL: this represents severe hypercalcemia and requires hospitalization regardless of trazodone use
• QTc above 500 ms on ECG: trazodone should be held and cardiology consulted
• New-onset confusion in an older adult on both agents: consider both drug toxicity and hypercalcemia as causes

Interaction Databases and Guideline Positions

Major drug-interaction databases classify the trazodone-calcium combination differently depending on methodology.

Drugs.com interaction checker lists no interaction between trazodone and calcium as of January 2025. The Natural Medicines Database (subscription-based clinical tool used by pharmacists) similarly does not flag a direct interaction but notes general cation-chelation caution for any multivalent mineral supplement. The Mayo Clinic drug-interaction tool returns no significant interaction for this pairing.

These negative findings are themselves informative. They reflect the absence of case reports, mechanistic plausibility, or signal from pharmacovigilance databases suggesting that calcium disrupts trazodone's therapeutic effect or safety profile in a clinically meaningful way.

The FDA prescribing information for trazodone hydrochloride lists known drug interactions with CYP3A4 inhibitors and inducers, digoxin, warfarin, and central nervous system depressants. Calcium is absent from this list. [4]

Frequently Asked Questions